Back to Woodline Partners LP Woodline Partners LP

TNGXTNGX
Showing 8 of 19 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in Tango Therapeutics, Inc.

Woodline Partners LP holds 4M shares of TNGX (Tango Therapeutics, Inc.), worth $125.1M as of 2026-Q2. The position was decreased (-50.0% shares). TNGX represents 0.4% of Woodline Partners LP's portfolio.

Current Value

$125.1M

Current Shares

4M

Total Value Change

+$125.1M

Total Shares Change

+4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4M
-50.0%
$125.1M0.4%$31.26
0
2026-Q1
Decreased
8M
-20.6%
$167.4M0.6%$11.50
0
2025-Q4
Increased
10.1M
+67.0%
$89.2M0.3%$8.63
53
2025-Q3
Increased
6M
0.0%
$50.7M0.2%$8.44
35
2025-Q2
Increased
6M
+1091.2%
$30.9M0.2%$5.01
56
2025-Q1
Increased
506,188
+28.3%
$693,4780.0%$1.47
31
2024-Q4
New
394,397
-
$1.2M0.0%$3.10
35
2024-Q3
Exited
0
-100.0%
$00.0%$7.47
0

Other major holders of TNGX: RTW INVESTMENTS, LP, BlackRock, Inc., FMR LLC, FARALLON CAPITAL MANAGEMENT, L.L.C., GOLDMAN SACHS GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used